Baltimore-Washington Financial Advisors, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baltimore-Washington Financial Advisors, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$486,000
+27.9%
20,502
-3.0%
0.07%
-2.9%
Q1 2020$380,000
-46.3%
21,127
-29.2%
0.07%
-33.7%
Q4 2019$708,000
-34.0%
29,850
-23.5%
0.10%
-40.9%
Q3 2019$1,072,000
-28.1%
39,023
-13.3%
0.18%
-29.9%
Q2 2019$1,490,000
-4.7%
45,033
+0.9%
0.25%
-8.1%
Q1 2019$1,563,000
+24.7%
44,613
+18.2%
0.27%
+5.4%
Q4 2018$1,253,000
-40.2%
37,739
-9.3%
0.26%
-31.7%
Q3 2018$2,096,00041,6300.38%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders